Eton Pharmaceuticals Inc (ETON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	9.52% 18.93	17.28	11.65	10.32	9.074
Cost Of Revenue	5.62% 7.004	7.421	5.171	4.022	3.448
Gross Profit	20.92% 11.92	9.861	6.476	6.302	5.626
Operating Expenses	29.70% 13.40	10.33	5.847	5.793	8.561
Interest Income/Expense	3.01% 1.198	1.163	-	0.211	0.222
Benefits Costs and Expenses	14.20% 21.45	18.78	12.16	9.823	12.06
Costs And Expenses	14.20% 21.45	18.78	12.16	9.823	12.06
Depreciation and Amortization	0.79% 1.005	1.013	0.355	0.278	0.261
Operating Income/Loss	213.83% -1.475	-0.47	0.629	0.509	-2.935
Income/Loss From Continuing Operations Before Tax	68.16% -2.519	-1.498	-0.511	0.501	-2.987
Income Tax Expense/Benefit	10.81% 0.066	0.074	0.087	-0.126	0.054
Income/Loss From Continuing Operations After Tax	64.44% -2.585	-1.572	-0.598	0.627	-3.041
Net Income/Loss	64.44% -2.585	-1.572	-0.598	0.627	-3.041
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.03% 26.89	26.89	25.87	0.0259	0.0258
Basic Earnings Per Share	66.67% -0.10	-0.06	-0.03	0.02	-0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALKS

$29.94

3.53%

ELAN

$18.43

5.50%

RDY

$14.34

1.34%

VTRS

$10.50

1.65%

NBIX

$144.10

2.64%

UTHR

$400.52

5.27%